Oxygen

氧气
  • 文章类型: Journal Article
    缺乏合适的供体阻碍了肺移植。以前,被认为是边缘或不足的供体被丢弃.然而,令人兴奋的新技术,例如离体肺灌注(EVLP),为肺移植提供者提供边缘供体同种异体移植物的扩展评估。这种动态评估平台导致了肺移植的增加,并允许提供者使用以前被丢弃的供体,从而扩大捐赠池。目前的灌注技术使用细胞或无细胞灌注液,两者都有明显的优点和缺点。灌注成分对于维持稳态环境至关重要,提供足够的代谢支持,减少炎症和细胞死亡,最终改善器官功能。灌注溶液必须含有足够的蛋白质浓度以维持适当的致癌压力。然而,电流灌注溶液通常导致液体通过肺内皮外渗,导致无意中的肺水肿和损伤。因此,有必要开发新的灌注溶液,以防止过度损伤,同时保持适当的细胞稳态。这里,我们描述了基于聚合人血红蛋白(PolyhHb)的氧载体作为灌注液的应用,以及可以在大鼠EVLP模型中测试该灌注液的方案.这项研究的目的是为肺移植社区提供设计和开发新的灌注解决方案的关键信息。以及在临床相关的翻译移植模型中测试它们的适当方案。
    Lung transplantation is hampered by the lack of suitable donors. Previously, donors that were thought to be marginal or inadequate were discarded. However, new and exciting technology, such as ex vivo lung perfusion (EVLP), offers lung transplant providers extended assessment for marginal donor allografts. This dynamic assessment platform has led to an increase in lung transplantation and has allowed providers to use donors that were previously discarded, thus expanding the donor pool. Current perfusion techniques use cellular or acellular perfusates, and both have distinct advantages and disadvantages. Perfusion composition is critical to maintaining a homeostatic environment, providing adequate metabolic support, decreasing inflammation and cellular death, and ultimately improving organ function. Perfusion solutions must contain sufficient protein concentration to maintain appropriate oncotic pressure. However, current perfusion solutions often lead to fluid extravasation through the pulmonary endothelium, resulting in inadvertent pulmonary edema and damage. Thus, it is necessary to develop novel perfusion solutions that prevent excessive damage while maintaining proper cellular homeostasis. Here, we describe the application of a polymerized human hemoglobin (PolyhHb)-based oxygen carrier as a perfusate and the protocol in which this perfusion solution can be tested in a model of rat EVLP. The goal of this study is to provide the lung transplant community with key information in designing and developing novel perfusion solutions, as well as the proper protocols to test them in clinically relevant translational transplant models.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    药物相关的颌骨坏死(MRONJ)可能是一种使人衰弱的并发症,可在服用或正在服用抗吸收(包括双膦酸盐)或抗血管生成药物的患者中出现,导致可见的骨头或瘘管持续八周以上,没有任何放疗史。该临床病例旨在描述使用blue®m口服凝胶的局部活性氧疗法治疗MRONJ。一名63岁的女性患者,通过口服每周服用阿仑膦酸钠(70毫克)四年,在#46区域表现出不适和植入物运动,然后接受了植入物的手术提取。三个月后,患者返回并被诊断为MRONJ。最初,进行了常规治疗,包括手术清创和抗生素治疗,但没有成功。植入物拔除后六个月,患者仍有骨坏死的临床体征。然后通过局部施用用blue®m口服凝胶填充整个插座。指示患者每8小时继续向该区域施用凝胶,持续15天。在这段时间之后,病人回来了,观察到伤口处于愈合过程中,有上皮化组织的存在,没有骨暴露。2年临床随访显示病灶已完全愈合,安装了新的植入物。骨整合期之后,最后的假体被放置。患者仍在临床随访中。因此,可以得出结论,在该临床病例中应用blue®m口服凝胶有助于骨坏死病变的恢复。
    Medication-related osteonecrosis of the jaw (MRONJ) can be a debilitating complication that can arise in patients who took or are taking antiresorptive (including bisphosphonates) or antiangiogenic agents, leading to visible bone or a fistula that continues for more than eight weeks, without any history of radiotherapy. This clinical case aimed to describe the treatment of MRONJ with topical active oxygen therapy using blue®m oral gel. A 63-year-old female patient that had been taking weekly sodium alendronate (70 mg) for four years by oral via, presented discomfort and implant movement in the #46 region, by that underwent surgical extraction of the implant. After three months the patient returned and was diagnosed with MRONJ. Initially, conventional therapies were performed, including surgical debridement and antibiotic therapy, but without success. The patient still had clinical signs of osteonecrosis six months after the implant extraction. The entire socket was then filled with blue®m oral gel by topical application. The patient was instructed to continue applying the gel to the region every 8 hours for 15 days. After this period, the patient returned, and it was observed that the wound was in the healing process, with the presence of epithelialized tissue and without bone exposure. The 2-year clinical follow-up showed the lesion had healed entirely, and a new implant was installed. After the osseointegration period, the final prosthesis was placed. The patient remains under clinical follow-up. Therefore, it can be concluded that the application of blue®m oral gel in this clinical case assisted in the recovery of the osteonecrosis lesion.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:这项研究的重点是评估微中风事件期间关键生理参数的破坏,以评估其严重程度。
    方法:建立了数学模型来模拟脑组织pO2,葡萄糖浓度,和血液流动中断导致的温度。该模型考虑了基线脑血流量(CBF)的变化,毛细管密度,和血氧/葡萄糖水平,以及环境温度的变化。
    结果:模拟表明,完全的血流阻塞仍然允许有限的葡萄糖供应,支持非氧化代谢并可能加剧乳酸积聚和酸中毒。部分阻塞降低组织pO2,对葡萄糖水平影响最小,可以保持几乎不变,甚至略有增加。降低CBF,毛细管密度,或血氧由于老化或疾病增加缺氧风险在较低的阻塞水平,毛细血管密度通过影响pO2和葡萄糖水平对中风严重程度有显著影响。条件可能导致缺氧/低血糖或缺氧/高血糖的同时发生,每一个恶化的结果。脑深部区域的温度影响很小,但根据环境温度,颅骨附近的温度变化为0.2-0.8°C。
    结论:该模型基于估计的缺氧水平提供了对导致严重中风结局的条件的见解,低血糖,高血糖症,和温度变化。
    OBJECTIVE: This study focuses on evaluating the disruptions in key physiological parameters during microstroke events to assess their severity.
    METHODS: A mathematical model was developed to simulate the changes in cerebral tissue pO2, glucose concentration, and temperature due to blood flow interruptions. The model considers variations in baseline cerebral blood flow (CBF), capillary density, and blood oxygen/glucose levels, as well as ambient temperature changes.
    RESULTS: Simulations indicate that complete blood flow obstruction still allows for limited glucose availability, supporting nonoxidative metabolism and potentially exacerbating lactate buildup and acidosis. Partial obstructions decrease tissue pO2, with minimal impact on glucose level, which can remain almost unchanged or even slightly increase. Reduced CBF, capillary density, or blood oxygen due to aging or disease enhances hypoxia risk at lower obstruction levels, with capillary density having a significant effect on stroke severity by influencing both pO2 and glucose levels. Conditions could lead to co-occurrence of hypoxia/hypoglycemia or hypoxia/hyperglycemia, each worsening outcomes. Temperature effects were minimal in deep brain regions but varied near the skull by 0.2-0.8°C depending on ambient temperature.
    CONCLUSIONS: The model provides insights into the conditions driving severe stroke outcomes based on estimated levels of hypoxia, hypoglycemia, hyperglycemia, and temperature changes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:在放疗的基础上,对缺氧膀胱癌患者进行缺氧修饰,但是没有生物标志物来识别缺氧肿瘤患者。我们,在这里,旨在在源自肌肉浸润性膀胱癌(MIBC)的异种移植物中实施氧增强MRI(OE-MRI),用于未来的缺氧生物标志物发现工作;并生成基因表达数据用于未来的生物标志物发现。
    方法:接种HT1376MIBC细胞的雌性CD-1裸鼠的侧腹。对具有小(300mm3)或大(700mm3)肿瘤的小鼠进行成像,在Agilant7T16cm口径磁体中注入吡莫硝唑1h后,使用动态MPRAGE采集的T2-TurboRARE序列与BrukerAvanceIII控制台连接。采集动态损坏梯度的回波图像5分钟,含0.1mmol/kgGd-DOTA(Dotarem,Guerbet,UK)在60s(1ml/min)后注射。匹配动态对比增强(DCE)-MRI和OE-MRI扫描的体素大小和视野。在DCE-MRI扫描中被认为灌注有显著对比后增强(p<0.05)的体素和组织被进一步分成pOxyE(常氧)和pOxyR(低氧)区域。在液氮中收获肿瘤,切片,提取RNA并使用Clarioms微阵列分析转录组。
    结果:成像的缺氧区域在较大与较小的肿瘤中更大。已知的缺氧诱导基因和24基因膀胱癌缺氧评分在吡莫硝唑高与低区域中的表达较高:CA9(p=0.012)和SLC2A1(p=0.012),表明预期的转录组学行为。
    结论:OE-MRI在MIBC来源的异种移植物中成功实施。来自低氧和非低氧异种移植区域的转录组数据将对未来的研究有用。
    OBJECTIVE: Patients with hypoxic bladder cancer benefit from hypoxia modification added to radiotherapy, but no biomarkers exist to identify patients with hypoxic tumours. We, herein, aimed to implement oxygen-enhanced MRI (OE-MRI) in xenografts derived from muscle-invasive bladder cancer (MIBC) for future hypoxia biomarker discovery work; and generate gene expression data for future biomarker discovery.
    METHODS: The flanks of female CD-1 nude mice inoculated with HT1376 MIBC cells. Mice with small (300 mm3) or large (700 mm3) tumours were imaged, breathing air then 100% O2, 1 h post injection with pimonidazole in an Agilant 7T 16cm bore magnet interfaced to a Bruker Avance III console with a T2-TurboRARE sequence using a dynamic MPRAGE acquisition. Dynamic Spoiled Gradient Recalled Echo images were acquired for 5 min, with 0.1mmol/kg Gd-DOTA (Dotarem, Guerbet, UK) injected after 60 s (1 ml/min). Voxel size and field of view of dynamic contrast enhanced (DCE)-MRI and OE-MRI scans were matched. The voxels considered as perfused with significant post-contrast enhancement (p<0.05) in DCE-MRI scans and tissue were further split into pOxyE (normoxic) and pOxyR (hypoxic) regions. Tumours harvested in liquid N2, sectioned, RNA was extracted and transcriptomes analysed using Clariom S microarrays.
    RESULTS: Imaged hypoxic regions were greater in the larger versus smaller tumour. Expression of known hypoxia-inducible genes and a 24 gene bladder cancer hypoxia score were higher in pimonidazole-high versus -low regions: CA9 (p=0.012) and SLC2A1 (p=0.012) demonstrating expected transcriptomic behaviour.
    CONCLUSIONS: OE-MRI was successfully implemented in MIBC-derived xenografts. Transcriptomic data derived from hypoxic and non-hypoxic xenograft regions will be useful for future studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Editorial
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    化学需氧量(COD)的测量在污水处理过程中非常重要。COD值在一定程度上反映了污水处理的效果和趋势,但是获得准确的数据需要很高的成本和劳动强度。TO1解决这个问题,提出了一种基于卷积神经网络-双向长短期记忆网络-注意力机制(CNN-BiLSTM-attention)算法的COD在线软测量方法。首先,通过分析厌氧-缺氧-氧化(A2O)废水处理过程中好氧池阶段的机理,初步确定了输入变量的选择范围,并对采集的样本数据集进行相关性分析。最后,pH值,溶解氧(DO),电导率(EC),和水温(T)被确定为COD软测量预测的输入变量。然后,基于CNN的特征提取能力和BiLSTM能够捕获时间序列数据中的后向和前向依赖的优势,结合可以为关键数据分配更高权重的注意力机制,建立了CNN-BiLSTM-Attention算法模型对A2O污水处理过程好氧区出水COD进行软测量。同时,均方根误差(RMSE),平均绝对误差(MAE),平均绝对百分比误差(MAPE)和决定系数(R2)三个指标用于评估模型,结果表明,该模型能够准确预测COD值,具有较高的准确性。同时,与CNN-LSTM-Attention等模型相比,CNN-BiLSTM,CNN-LSTM,LSTM,RNN,BP,SVM,XGBoost,和RF等。,结果表明,CNN-BiLSTM注意力模型表现最好,证明了算法模型的优越性。Wilcoxon符号秩检验表明CNN-BiLSTM-注意力模型与其他模型之间存在显著差异。
    The measurement of chemical oxygen demand (COD) is very important in the process of sewage treatment. The value of COD reflects the effectiveness and trend of sewage treatment to a certain extent, but obtaining accurate data requires high cost and labor intensity. To1 solve this problem, this paper proposes an online soft measurement method for COD based on Convolutional Neural Network-Bidirectional Long Short-Term Memory Network-Attention Mechanism (CNN-BiLSTM-Attention) algorithm. Firstly, by analyzing the mechanism of the aerobic tank stage in the Anaerobic-Anoxic-Oxic (A2O) wastewater treatment process, the selection range of input variables was preliminarily determined, and the collected sample dataset was subjected to correlation analysis. Finally, pH, dissolved oxygen (DO), electrical conductivity (EC), and water temperature (T) were determined as input variables for soft measurement prediction of COD.Then, based on the feature extraction ability of CNN and the advantage that BiLSTM is able to capture the backward and forward dependencies in time series data, combined with the attention mechanism that can assign higher weights to the key data, a CNN-BiLSTM-Attention algorithm model was established to soft measure COD in the effluent from the aerobic zone of the A2O wastewater treatment process. At the same time, root mean square error (RMSE), mean absolute error (MAE), mean absolute percentage error (MAPE) and coefficient of determination (R2) were utilized Three indicators were used to evaluate the model, and the results showed that the model can accurately predict the value of COD and has a high accuracy. At the same time, compared with models such as CNN-LSTM-Attention, CNN-BiLSTM, CNN-LSTM, LSTM, RNN, BP, SVM, XGBoost, and RF etc., the results showed that the CNN-BiLSTM Attention model performed the best, proving the superiority of the algorithm model.The Wilcoxon signed-rank test indicates significant differences between the CNN-BiLSTM-Attention model and other models.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    肝脏缺血再灌注损伤(LIRI)是一个涉及多种损伤因子和细胞类型的病理过程,有不同的阶段。目前,针对单一病症的保护性药物疗效有限,对免疫细胞的干预也会伴随一系列副作用。在当前的瓶颈研究阶段,多靶点、临床疗效明显的中药有望成为新药研发的突破口。在这次审查中,我们总结了活性氧(ROS)和活性氮(RNS)在肝缺血再灌注的各个阶段和各种类型的细胞中的作用。结合目前用CM降低ROS/RNS的研究进展,讨论了肝缺血再灌注治疗的新疗法和机制。
    Liver ischemia-reperfusion injury (LIRI) is a pathological process involving multiple injury factors and cell types, with different stages. Currently, protective drugs targeting a single condition are limited in efficacy, and interventions on immune cells will also be accompanied by a series of side effects. In the current bottleneck research stage, the multi-target and obvious clinical efficacy of Chinese medicine (CM) is expected to become a breakthrough point in the research and development of new drugs. In this review, we summarize the roles of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in various stages of hepatic ischemia-reperfusion and on various types of cells. Combined with the current research progress in reducing ROS/RNS with CM, new therapies and mechanisms for the treatment of hepatic ischemia-reperfusion are discussed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    缺血性卒中患者血糖水平升高与预后较差相关。本研究旨在探讨高血糖是否通过增加急性缺血性卒中模型的氧提取率来促进小胶质细胞凋亡。将经历大脑中动脉闭塞的C57BL/6小鼠用于评估血糖水平和神经功能。脑氧提取率(CERO2),测定氧消耗率(OCR)和脑组织氧分压(PbtO2)。探讨NOD样受体蛋白3(NLRP3)炎症小体的意义,使用NLRP3-/-小鼠,和NLRP3,caspase‑1,全长gasderminD(GSDMD‑FL)的表达水平,GSDMD‑N域(GSDMD‑N),评估IL‑1β和IL‑18。此外,Z‑YVAD‑FMK,caspase-1抑制剂,用于治疗小胶质细胞,以确定是否需要激活NLRP3炎性体来增强高血糖对焦亡的作用。提示高血糖加速急性缺血性卒中模型的脑损伤,下降的潜伏期减少和足断层的百分比证明了这一点。高血糖通过增加氧提取率来加重缺氧,正如CERO2和OCR增加所证明的那样,和响应高糖治疗的PbtO2降低。此外,通过检测caspase‑1,GSDMD‑N水平升高证实了高血糖诱导的小胶质细胞焦亡,IL‑1β和IL‑18以及GSDMD‑FL水平降低。然而,NLRP3的敲除减弱了这些作用。caspase-1的药理学抑制也降低了GSDMD-N的表达水平,小胶质细胞中的IL‑1β和IL‑18。这些结果表明,高血糖通过增加氧提取速率刺激NLRP3炎性体激活,从而导致缺血性中风后的焦度加重。
    Elevated levels of blood glucose in patients with ischemic stroke are associated with a worse prognosis. The present study aimed to explore whether hyperglycemia promotes microglial pyroptosis by increasing the oxygen extraction rate in an acute ischemic stroke model. C57BL/6 mice that underwent middle cerebral artery occlusion were used for assessment of blood glucose level and neurological function. The cerebral oxygen extraction ratio (CERO2), oxygen consumption rate (OCR) and partial pressure of brain tissue oxygen (PbtO2) were measured. To investigate the significance of the NOD‑like receptor protein 3 (NLRP3) inflammasome, NLRP3‑/‑ mice were used, and the expression levels of NLRP3, caspase‑1, full‑length gasdermin D (GSDMD‑FL), GSDMD‑N domain (GSDMD‑N), IL‑1β and IL‑18 were evaluated. In addition, Z‑YVAD‑FMK, a caspase‑1 inhibitor, was used to treat microglia to determine whether activation of the NLRP3 inflammasome was required for the enhancing effect of hyperglycemia on pyroptosis. It was revealed that hyperglycemia accelerated cerebral injury in the acute ischemic stroke model, as evidenced by decreased latency to fall and the percentage of foot fault. Hyperglycemia aggravated hypoxia by increasing the oxygen extraction rate, as evidenced by increased CERO2 and OCR, and decreased PbtO2 in response to high glucose treatment. Furthermore, hyperglycemia‑induced microglial pyroptosis was confirmed by detection of increased levels of caspase‑1, GSDMD‑N, IL‑1β and IL‑18 and a decreased level of GSDMD‑FL. However, the knockout of NLRP3 attenuated these effects. Pharmacological inhibition of caspase‑1 also reduced the expression levels of GSDMD‑N, IL‑1β and IL‑18 in microglial cells. These results suggested that hyperglycemia stimulated NLRP3 inflammasome activation by increasing the oxygen extraction rate, thus leading to the aggravation of pyroptosis following ischemic stroke.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    缺氧(OD)是一种危重症,可导致脑损伤甚至死亡。目前的缺氧管理方法的有效性有限。积雪草(CA),以其神经保护特性而闻名,为OD治疗提供了潜在的替代方案。
    本研究旨在研究缺氧条件下CA对斑马鱼幼虫脑源性神经营养因子(BDNF)和囊泡谷氨酸转运蛋白1(VGLUT1)表达的神经保护作用。
    斑马鱼胚胎接受低氧水平(1.5mg/l)受精后0-2小时(hpf),直到受精后3天(dpf),模拟OD的早期阶段。随后的治疗涉及不同浓度的CA(1.25-5µg/ml),直至受精后9天。使用PCR方法测量BDNF和VGLUT1的表达水平。使用双向方差分析进行统计分析,以评估CA对在缺氧条件下3和9dpf的斑马鱼幼虫中BDNF和VGLUT1表达的影响。
    CA显著影响OD下BDNF和VGLUT1的表达(p<0.001)。在经历OD并用CA处理的斑马鱼幼虫中观察到BDNF表达的增加(p<0.001)和VGLUT1的减少(p<0.01)。在3dpf和9dpf的斑马鱼幼虫中,BDNF和VGLUT1表达在年龄变化中在治疗组中没有显着差异(p>0.05)。2.5µg/ml的CA浓度可有效增强BDNF并降低3-9dpf斑马鱼幼虫的VGLUT1。
    CA显示出作为神经保护剂的潜力,在OD条件下调节增加的BDNF表达和降低的VGLUT1。这些发现为进一步开发缺氧疗法奠定了基础。
    UNASSIGNED: Oxygen deprivation (OD) is a critical condition that can lead to brain damage and even death. Current hypoxia management approaches are limited in effectiveness. Centella asiatica (CA), known for its neuroprotective properties, offers a potential alternative for OD treatment.
    UNASSIGNED: This study aims to investigate the neuroprotective effects of CA on the expression of brain-derived neurotrophic factor (BDNF) and vesicular glutamate transporter 1 (VGLUT1) in zebrafish larvae under oxygen-deficient conditions.
    UNASSIGNED: Zebrafish embryos were subjected to low oxygen levels (1.5 mg/l) 0-2 hours post-fertilization (hpf) until 3 days post-fertilization (dpf), simulating the early stages of OD. Subsequent treatment involved varying concentrations of CA (1.25-5 µg/ml) up to 9 days post-fertilization. The expression levels of BDNF and VGLUT1 were measured using PCR methods. Statistical analysis was conducted using a two-way analysis of variance to evaluate the impact of CA on the expression of BDNF and VGLUT1 in zebrafish larvae aged 3 and 9 dpf in oxygen-deprived conditions.
    UNASSIGNED: CA significantly influenced the expression of BDNF and VGLUT1 under OD (p < 0.001). An increase in BDNF expression (p < 0.001) and a decrease in VGLUT1 (p < 0.01) were observed in zebrafish larvae experiencing OD and treated with CA. There was no significant difference in BDNF and VGLUT1 expression across age variations in zebrafish larvae at 3 dpf and 9 dpf in the treatment groups (p > 0.05). CA concentration of 2.5 µg/ml effectively enhanced BDNF and reduced VGLUT1 in 3-9 dpf zebrafish larvae.
    UNASSIGNED: CA demonstrates potential as a neuroprotective agent, modulating increased BDNF expression and reduced VGLUT1 under OD conditions. These findings lay a foundation for further research in developing therapies for oxygen deficiency.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在过去的十年中,高流量鼻插管(HFNC)在治疗细支气管炎中的使用显着增加。然而,随机对照试验报告说,早期的临床益处很小,常规使用。本文简要概述了HFNC治疗的现状,讨论了成功的取消实施策略,以减少HFNC的过度使用,并探讨了未来毛细支气管炎和HFNC质量改进和研究注意事项。
    The use of high flow nasal cannula (HFNC) in the treatment of bronchiolitis has markedly increased in the last decade, yet randomized controlled trials have reported little clinical benefit with early, routine use. This article provides a concise overview of the current status of HFNC therapy, discusses successful de-implementation strategies to curtail HFNC overuse, and explores future bronchiolitis and HFNC quality improvement and research considerations.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号